JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

115 hedge funds and large institutions have $271M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-15
Holders Change %
-11.54%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
11
Increased
44
Reduced
35
Closed
25
Calls
$570K
Puts
$180K
Net Calls
+$390K
Net Calls Change
+$1.78M
Name Holding Trade Value Shares
Change
Shares
Change %
TI
126
Trexquant Investment
Connecticut
-$227K -33,322 Closed
XT
127
XTX Topco
Cayman Islands
-$204K -29,928 Closed
ECM
128
ExodusPoint Capital Management
New York
-$177K -26,064 Closed
EGM
129
Engineers Gate Manager
New York
-$167K -24,500 Closed
HF
130
HRT Financial
New York
-$151K -22,255 Closed
MGB
131
Mass General Brigham
Massachusetts
-$131K -19,291 Closed
HSA
132
Hussman Strategic Advisors
Maryland
-$105K -15,500 Closed
PP
133
PDT Partners
New York
-$102K -15,009 Closed
Susquehanna International Group
134
Susquehanna International Group
Pennsylvania
-$82K -12,108 Closed
HW
135
Hancock Whitney
Mississippi
-$79K -11,664 Closed
PCM
136
Prelude Capital Management
New York
-$78K -11,400 Closed
PHK
137
Point72 Hong Kong
Hong Kong
-$31K -4,606 Closed
MCM
138
MV Capital Management
Maryland
-$3K -500 Closed